Patil H, Feng X, Ye X, Majumdar S, Repka MA (2015) Continuous production of fenofibrate solid

lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by

design approach. AAPS J 17(1):194–105

Peltonen L (2018) Design space and QbD approach for production of drug nanocrystals by wet

media milling techniques. Pharmaceutics 10(3):104–108

Pitta SK, Dudhipala N, Narala A, Veerabrahma K (2018) Development of zolmitriptan

transfersomes by Box–Behnken design for nasal delivery: in vitro and in vivo evaluation.

Drug Deliv Ind Pharm 44(3):484–492

Prud’homme RK, Svenson S (2012) Introduction: benefits and challenges for multifunctional

nanoparticles in medicine. In: Svenson S, Prud’homme RK (eds) Multifunctional nanoparticles

for drug delivery applications. Springer, München, pp 1–5

Rana V, Kamboj S, Sethi S (2018) Lipid-based nanocarriers in lymphatic transport of drugs:

retrospect and prospects. In: Singh B, Ho JYR, Kanwar J (eds) NanoBioMaterials. CRC

Press, Boca Raton, pp 67–96

Rangaraj N, Pailla SR, Shah S, Prajapati S, Sampathi S (2020) QbD aided development of ibrutinib-

loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomi-

cron flow blocking approach. Drug Deliv Transl Res 10:1476–1494

Raviadaran R, Chandran D, Shin LH, Manickam S (2018) Optimization of palm oil in water nano-

emulsion with curcumin using microfluidizer and response surface methodology. LWT 96:58–

65

Raza K, Singh B, Singla S, Wadhwa S, Garg B, Chhibber S et al (2013) Nanocolloidal carriers of

isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic

modeling. Mol Pharm 10(5):1958–1963

Re F, Gregori M, Masserini M (2012) Nanotechnology for neurodegenerative disorders.

Nanomedicine 8:S51–S58

Sanganwar GP, Sathigari S, Babu RJ, Gupta RB (2010) Simultaneous production and co-mixing of

microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution

enhancement. Eur J Pharm Sci 39(1–3):164–174

Sathigari SK, Ober CA, Sanganwar GP, Gupta RB, Babu RJ (2011) Single-step preparation and

deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution

enhancement. J Pharm Sci 100(7):2952–2965

Schwartz JB, Connor RE (1996) Optimization techniques in pharmaceutical formulation and

processing. In: Banker GS, Rhodes CT (eds) Modern pharmaceutics. Marcel Dekker, New York

Shah A, Jameel F, Patel SM (2015) Application of QbD principles for Lyophilized formulation

development. In: Quality by design for biopharmaceutical drug product development. Springer,

New York, NY, pp 137–158

Shah S, Parmar B, Soniwala M, Chavda J (2016) Design, optimization, and evaluation of lurasidone

hydrochloride nanocrystals. AAPS PharmSciTech 17:1150–1158

Shamekhi F, Tamjid E, Khajeh K (2018) Development of chitosan coated calcium-alginate

nanocapsules for oral delivery of liraglutide to diabetic patients. Int J Biol Macromol 120:

460–467

Sharma G, Beg S, Thanki K, Katare OP, Jain S, Kohli K et al (2015) Systematic development of

novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with

enhanced biopharmaceutical performance. RSC Adv 5(87):71500–71513

Sharma G, Thakur K, Raza K, Singh B, Katare OP (2017) Nanostructured lipid carriers: a new

paradigm in topical delivery for dermal and transdermal applications. Crit Rev Ther Drug

Carrier Syst 34(4):355–386

Sharma R, Dubey S, Mody N, Sharma G, Kushwah V, Jain S et al (2018) Release promoter-based

systematically designed nanocomposite(s): a novel approach for site-specific delivery of tumor-

associated antigen(s) (TAAs). Artif Cells Nanomed Biotechnol 46:1–14

Sharma T, Jain A, Kaur R, Saini S, Katare OP, Singh B (2020) Supersaturated LFCS type III self-

emulsifying delivery systems of sorafenib tosylate with improved biopharmaceutical perfor-

mance: QbD-enabled development and evaluation. Drug Deliv Trans Res 10:839–861

Shukla A, Singh B, Katare OP (2011) Significant systemic and mucosal immune response induced

on oral delivery of diphtheria toxoid using nano-bilosomes. Br J Pharmacol 164(2b):820–827

348

B. Singh et al.